Peptides DB
Research-centric peptide and protocol reference hub
Study 15 of 17Zenagamtide literatureMedComm · Review2026

Obstructive Sleep Apnea: Epidemiology, Pathophysiology, Complications, Diagnosis, Management, and Emerging Fibrosis-Linked Remodeling.

OSA is a complex systemic disease with potential fibrosis-linked remodeling effects, requiring more nuanced diagnostic metrics than currently used.

Read at MedCommAdd to compare

Where it sits

this study against the rest of the zenagamtide corpus
4
Preclinical
8
Observational
0
Open-label
3
Randomised
2
Reviews · this one

Summary and findings

This review discusses the epidemiology, pathophysiology, complications, diagnosis, and management of obstructive sleep apnea (OSA), with a focus on fibrosis-linked remodeling. It emphasizes the limitations of conventional severity classifications and suggests physiologically enriched metrics for better risk assessment. The review also highlights the potential role of OSA in structural remodeling of various organs.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
2026

Abstract

The authors’ words, as MedComm supplied them

Obstructive sleep apnea (OSA) is a highly prevalent yet substantially underdiagnosed sleep-related breathing disorder increasingly recognized as a heterogeneous systemic disease rather than a purely mechanical consequence of recurrent upper-airway collapse. This review provides an updated and integrated overview of OSA, spanning epidemiology, multifactorial pathophysiology, heterogeneous clinical presentation, major cardiometabolic and end-organ consequences, diagnostic principles, and evolving personalized management, while also emphasizing the limitations of conventional severity classification, which is predominantly based on the apnea-hypopnea index. We highlight how intermittent hypoxia-reoxygenation, sleep fragmentation, sympathetic activation, intrathoracic pressure stress, endothelial dysfunction, inflammation, oxidative stress, and metabolic dysregulation interact to drive systemic injury, and why physiologically enriched metrics such as hypoxic burden, T90, event duration, sleep-stage dependency, and endotypic heterogeneity may better capture biological risk than event frequency alone. Within this broader framework, fibrosis-linked structural remodeling emerges as an important yet under-supported dimension of OSA pathobiology. Experimental and clinical evidence suggests that OSA may contribute to remodeling of the lungs, liver, kidneys, and heart, although the strength of the evidence and the degree of causal inference vary across organs. By integrating established knowledge with this emerging fibrosis-oriented perspective, this review defines key mechanistic, diagnostic, and translational priorities for future research and phenotype-aware clinical stratification.

Background

Obstructive sleep apnea (OSA) is increasingly recognized as a systemic disease with significant underdiagnosis. Traditional views consider it a mechanical issue due to upper-airway collapse, but emerging perspectives highlight its multifactorial pathophysiology. This review is significant as it integrates new insights into fibrosis-linked remodeling, potentially expanding the understanding of OSA's systemic impacts.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

This review synthesizes existing knowledge and emerging perspectives on OSA, particularly focusing on fibrosis-linked remodeling. While it provides a comprehensive overview, the lack of new experimental data limits its ability to establish causality. The review suggests that physiologically enriched metrics could improve risk assessment, but further research is needed to validate these approaches.

Key findings

  • OSA is a highly prevalent and underdiagnosed disorder.
  • Conventional severity classification is limited by reliance on the apnea-hypopnea index.
  • Physiologically enriched metrics may better capture biological risk.
  • OSA may contribute to fibrosis-linked remodeling of lungs, liver, kidneys, and heart.
  • The strength of evidence for organ remodeling varies across organs.

Limitations

  • Narrative review, no new data
  • Causal inference varies across organs
  • Limited by reliance on existing literature

Elsewhere in the Zenagamtide corpus

CTargeting oxidative stress-NLRP3-apoptotic-steroidogenic axis in doxorubicin-induced testicular toxicity: protective efficacy of ferulic acid niosomes.Biological research · 2026 · n=40 · Not reported in abstract.AnimalCLymphatic Targeting of Flubendazole via Long-Chain Fatty Acid Nanoemulsion: Pharmacokinetic Evidence of Chylomicron-Mediated Uptake in Rats.ACS omega · 2026 · C_max = 2.42 ± 0.34 μg/mL for FLZ-NEAnimalBApplication of Clinical Indicators in the Early Prediction of Refractory &lt;i&gt;Mycoplasma pneumoniae&lt;/i&gt; Pneumonia in Children: A Retrospective Study.Clinical pediatrics · 2026 · n=223 · The combined model's area under the curve was 0.946.HumanBRisk factors associated with malnutrition in elderly patients with chronic heart failure.Medicine · 2024 · n=203 · Area under the curve of 0.902 for the final model.HumanBSubfoveal Choroidal Thickness is Independently Associated with Axial Length and Myopia in Preschool Children: A Swept-Source Optical Coherence Tomography Study.Ophthalmology and therapy · 2026 · n=303 · Mean SFCT was 326.33 ± 43.01 μm in children aged 3-6 years.HumanBEffects of the combination therapy of hemodialysis with hemoperfusion on medium molecular toxins and protein bound uremic toxins in maintenance hemodialysis patients.Blood purification · 2026 · n=38 · β2-MG reduced from 29.72±5.61 to 21.50±6.69 μg/ml, t=5.882, P<0.001Human